Skip to Content
Merck
CN
  • Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma.

Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma.

Frontiers in pharmacology (2017-11-01)
Begoña Fonseca, Alejandro Martínez-Águila, María J Pérez de Lara, Maria Teresa Miras-Portugal, Rosa Gómez-Villafuertes, Jesús Pintor
ABSTRACT

Glaucoma is a neuropathology, often accompanied by an elevated intraocular pressure (IOP), which can lead to blindness. Since DBA/2J mice develop glaucoma, several studies of the physiopathology of glaucoma have been reported in this animal model. It is also known that purinergic receptors are involved in the pathology of glaucoma by controlling aqueous humor production and drainage and therefore controlling IOP. There are no studies on purinergic receptors in the DBA/2J model of glaucoma and their relation to the development of the pathology, so the aim of this study was to make an approach to the purinergic mechanisms involved in glaucoma. All the experiments were performed using DBA/2J and C57BL/6J mice and investigating P2Y